Eveliqure secures further private investment to support development of its combined Shigella and ETEC vaccine candidate

30 June 2020

Read more

CEBINA secures seed funding for its unique extended spectrum Coronavirus vaccine

4 June 2020

Read more

Eveliqure Biotechnologies announces regulatory approval to initiate first clinical trial of its ShigETEC vaccine candidate

2 June 2020

Read more

Calyxha Biotechnologies announces grant of a European Patent on neurodegenerative diseases

20 April 2020

Read more

CEBINA today announces the initiation of several collaborative projects that address the global health crisis caused by the pandemic spread of the SARSCoV-2 virus.

17 April 2020

Read more

Calyxha Biotechnologies announces new financing to support pre-clinical development of its therapeutic lead candidate, CAL-X

4 March 2020

Read more

CEBINA hosted a successful launch event today at our Vienna facility

16 December 2019

Read more

Our resident company Eveliqure Biotechnologies GmbH announces a grant from the Wellcome Trust to support their effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries.

5 November 2019

https://www.eveliqure.com/news